| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Strategy &Corporate Dev | EVP Strategy And Corporate Dev | EVP Strategy &Corp Dev +3 more
1 company
Dolan Matthew Vincent is an EVP, Strategy &Corporate Dev at DEXCOM INC. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $2.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2022 | DXCM Dexcom Inc | SVP Corporate Development | Sell | 2,186 | $424.68 | $928,358.56 | -9.2% | -37.1% | +0.2% |